SPONSOR
Nationwide Children's Hospital
Total Trials
5
Recruiting
5
Phases
Phase 2, Phase 1, Phase 1, Phase 2
Conditions studied: Peripheral Artery DiseaseDiabetes MellitusChronic Limb-Threatening IschemiaSickle Cell DiseaseAdamantinomatous CraniopharyngiomaRecurrent Adamantinomatous CraniopharyngiomaHigh Grade GliomaAcute Myeloid Leukemia
Nationwide Children's Hospital is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Peripheral Artery Disease, Diabetes Mellitus, Chronic Limb-Threatening Ischemia, Sickle Cell Disease.
The trial portfolio spans Phase 2, Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Nationwide Children's Hospital
How many clinical trials has Nationwide Children's Hospital sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Nationwide Children's Hospital, of which 5 are actively recruiting participants. These trials cover conditions including Peripheral Artery Disease, Diabetes Mellitus, Chronic Limb-Threatening Ischemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nationwide Children's Hospital research focus on?
Nationwide Children's Hospital clinical trials span Peripheral Artery Disease, Diabetes Mellitus, Chronic Limb-Threatening Ischemia, Sickle Cell Disease, Adamantinomatous Craniopharyngioma, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Nationwide Children's Hospital clinical trial?
To participate in a Nationwide Children's Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nationwide Children's Hospital trials with current recruitment status updated daily.
Clinical Trials by Nationwide Children's Hospital
NCT03622359
Recruiting
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Peripheral Artery Disease
NCT06264700
Recruiting
Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness
Sickle Cell Disease
NCT05233397 Phase 2
Recruiting
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Adamantinomatous Craniopharyngioma
NCT04254419 Phase 1
Recruiting
Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
High Grade Glioma
NCT05503134 Phase 1, Phase 2
Recruiting
Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML
Acute Myeloid Leukemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology